Skip to content

Precision Anticoagulation in Real-World Patients With Atrial Fibrillation–Related Acute Ischemic Stroke: A Multicenter Registry Study

Precision Anticoagulation in Real-World Patients With Atrial Fibrillation–Related Acute Ischemic Stroke: A Multicenter Registry Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115617
Enrollment
Unknown
Registered
2025-12-29
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lschemic Stroke

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1.Meet the diagnostic criteria for acute ischemic stroke according to the 2018 Chinese Guidelines; 2.Symptom onset to hospital presentation <= 7 days; 3.Documented atrial fibrillation or AF detected by 12-lead ECG, Holter monitoring, or in-hospital cardiac telemetry; 4.Receive anticoagulation therapy during hospitalization and/or for secondary prevention (intravenous, subcutaneous, or oral anticoagulants); 5.Provide written informed consent personally or via an authorized representative.

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1.Presence of moderate-to-severe mitral stenosis or history of mechanical/bioprosthetic valve replacement; 2.Self-discharge with an expected survival = 3;

Design outcomes

Primary

MeasureTime frame
Major cardiovascular adverse events and bleeding events;All-cause mortality;

Secondary

MeasureTime frame
Changes in anticoagulant therapy;modified Rankin Scale score;

Countries

China

Contacts

Public ContactRui Wang

The Second Affiliated Hospital of Soochow University

ruiwang0830@163.com+86 177 6802 0685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026